This study extends value-based insurance design concepts in testing the impact on blood pressure control of rewards that provided negative co-payments for blood pressure medication.
Stephen E. Kimmel, MD, MSCE
Advertisement
Articles by Stephen E. Kimmel, MD, MSCE
This study tests the impact on blood pressure control of a reward that lowered co-payments for blood pressure medication to $0.
Advertisement
Latest Updated Articles
- A Randomized Controlled Trial of Co-Payment Elimination: The CHORD Trial
Published: September 30th 2015 | Updated:
- A Randomized Controlled Trial of Negative Co-Payments: The CHORD Trial
Published: September 30th 2015 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Promises and Pitfalls of AI in Health Care
2
Paul Ryan Champions Health Care Policy Reform, AI Amid Government Shutdown
3
Zanubrutinib Safe, Effective in Real-World CLL/SLL Cohort
4
Delivering Value-Based Oncology Care in the Age of Biomarker Testing, Targeted Therapies, and Immunotherapies
5
